Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

The 'Robotic Prostatectomy Artificial Intelligence Low Pressure Pain Study Trial' aims to assess the feasibility of being able to review operative outcomes such as pain when comparing two commonly used surgical devices for the removal of prostate cancers. The data collected will inform methodologies for future, larger, multi-center trials investigating pain in patients undergoing prostate cancer surgery. A robotic prostatectomy is a commonly performed surgery used to treat prostate cancer by removing the prostate gland. In order to perform the procedure, the surgeon must 'inflate' (technical

Trial Details

NCT ID
NCT06915909
Phase
NA
Sponsor
East and North Hertfordshire NHS Trust
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • surgery
Locations (sample)
  • Stevenage, Hertfordshire, United Kingdom|51.90224,-0.20256

Key Eligibility Criteria

  • Patient indicated for non-emergent robotic Prostatectomy surgery
  • Patients (or appropriate legal representatives) able to provide written informed consent to participate in the study
  • Males, aged 18 to 75 years
  • Have no significant psychopathology that could limit the subject's ability to understand the procedure, comply with medical, surgical, and/or behav…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →